Enhances hepatic insulin sensitivity</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\"><xref rid=\"B66-biomedicines-10-00331\" ref-type=\"bibr\">66</xref></td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Statin</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">For diabetic dyslipidemia</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">\n</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">\n</td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Adiponectin</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Decreased adiponectin levels are thought to play<break/>a central role in the development of type 2 diabetes and obesity</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">AdipoRon is a novel orally-active small molecule that serves as a potent selective agonist of the AdipoR1 and AdipoR2 adiponectin receptors</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\"><xref rid=\"B67-biomedicines-10-00331\" ref-type=\"bibr\">67</xref><xref rid=\"B68-biomedicines-10-00331\" ref-type=\"bibr\">68</xref></td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Glut4</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Triggering the canonical PI3K-AKT pathway is essential and ample to activate exocytosis of GLUT4 storage vesicles to the plasma membrane</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Staurosporine is used to promotes GSVs translocation and glucose uptake through the AMPK pathway<break/>Rutamarin as a dual inducer of both GLUT4 translocation and expression efficiently ameliorates glucose homeostasis in insulin-resistant mice</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\"><xref rid=\"B69-biomedicines-10-00331\" ref-type=\"bibr\">69</xref><xref rid=\"B70-biomedicines-10-00331\" ref-type=\"bibr\">70</xref></td></tr><tr><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">PGC-1alpha</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Reduction in PGC-1alpha triggers insulin resistance and ultimately causes diabetes</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\">Still waiting to synthesize agonist</td><td align=\"center\" valign=\"middle\" style=\"border-bottom:solid thin\" rowspan=\"1\" colspan=\"1\"><xref rid=\"B71-biomedicines-10-00331\" ref-type=\"bibr\">71</xref><xref rid=\"B72-biomedicines-10-00331\" ref-type=\"bibr\">72</xref></td></tr></tbody></table>\n"}, "text": "Targets\tMechanism of Action\tLeads\tRef.\t \t11beta-HSD1(hydroxysteroid dehydrogenase)\tBlocking cortisol\t1. INCB13739, MK-0916, 2. BI 135585\t\t \tG protein-coupled receptor (GPR119) \tIncreases cAMP signaling\tAPD5979, MBX-2982\t\t \tTGR5 (bile-acid activated GPCR)\tcAMP accumulation and enhances GLP-1 secretion (intestine), anti-inflammatory effect (liver) \tINT-777\t\t \tSIRT1\tImproves insulin sensitivity, increases glucose homeostasis, increases mitochondrial capacity\tSRT2104, resveratrol\t\t \tSGLT-2\tIncreases kidney-dependent glucose homeostasis\tDapagliflozin, canagliflozin, sergliflozin, remogliflozin, ipragliflozin, and empagliflozin, etc.\t\t \tGPR40\tIncreases incretin secretion, improves glucose tolerance\tModulators \t\t \tPPAR-gamma\tImproves serum lipid profile, glucose homeostasis, insulin sensitivity, reduces inflammation and weight gain\tPiolitazone, aleglitazar, glitazones, GFT505\t\t \tTyrosine Kinase\tReduces beta cell apoptosis, enhances insulin secretion, increases beta cell survival, reduces insulin resistance, \tImatinib, Sunitinib, Dasatinib, Sorafenib, Erlotinib\t\t \tPPLR \tImproves JAK2/STAT5 pathway for glucose uptake\tBromocriptine\t\t \tInsulin degrading enzyme (IDE)\tThiol zinc-metalloendopeptidase that cleaves small proteins of diverse sequence\tBDM44768, 6bK, NTE-1\t\t \tFATP5\tEnhances the uptake of long-chain and very long-chain fatty acids into the cells\tChenodiol and Ursodiol \t\t \tSestrin\tEnhances hepatic insulin sensitivity\t3.